Therapeutic effect and rebound evaluation of dapagliflozin on glycated hemoglobin (HbA1c) in type 1 diabetes mellitus patients

Dapagliflozin has been used to treat patients with type 1 diabetes mellitus; however, the actual drug efficacy of dapagliflozin on glycated hemoglobin (HbA1c) and whether there is a rebound from dapagliflozin efficacy on HbA1c remain unknown. The present study aimed to explore the actual therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Dong-Dong, Zhang, Cun, Hu, Ke, He, Su-Mei, Zhu, Ping, Chen, Xiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845776/
https://www.ncbi.nlm.nih.gov/pubmed/36686651
http://dx.doi.org/10.3389/fphar.2022.972878

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845776/
https://www.ncbi.nlm.nih.gov/pubmed/36686651
http://dx.doi.org/10.3389/fphar.2022.972878

Ejemplares similares